Welcome to LookChem.com Sign In|Join Free
  • or
URSODEOXYCHOLIC-2,2,4,4-D4 ACID, also known as Ursodeoxycholic acid-d4 (UDCA-d4), is a deuterated form of Ursodeoxycholic acid (UDCA). It is a secondary bile acid formed via epimerization of chenodeoxycholic acid (CDCA) and is also a metabolite of lithocholic acid (LCA) in human liver microsomes. UDCA-d4 is used as an internal standard for the quantification of UDCA by gas chromatography (GC) or liquid chromatography-mass spectrometry (LC-MS). It possesses properties that make it a valuable tool in the analysis and quantification of bile acids, particularly in the context of medical and pharmaceutical research.

347841-46-7

Post Buying Request

347841-46-7 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

347841-46-7 Usage

Uses

Used in Pharmaceutical Research and Analysis:
URSODEOXYCHOLIC-2,2,4,4-D4 ACID is used as an internal standard for the quantification of UDCA in pharmaceutical research and analysis. It aids in the accurate measurement of UDCA levels by GCor LC-MS, ensuring reliable and precise results.
Used in Cholelithogenic Applications:
URSODEOXYCHOLIC-2,2,4,4-D4 ACID is used as an anticholelithogenic agent, which means it helps prevent the formation of gallstones. Its properties make it a useful compound in the development of treatments for conditions related to bile acid imbalances and gallstone formation.
Used in Bile Acid Quantification:
URSODEOXYCHOLIC-2,2,4,4-D4 ACID is used as an internal standard for rapid quantification of bile acids by liquid chromatography-tandem mass spectrometry. This application allows for the efficient and accurate measurement of bile acid levels in various biological samples, which is crucial for understanding and managing conditions related to bile acid metabolism.
Used in the Treatment of Primary Biliary Cirrhosis:
Formulations containing URSODEOXYCHOLIC-2,2,4,4-D4 ACID have been used in the treatment of primary biliary cirrhosis, a chronic liver disease. Its presence in these formulations contributes to the therapeutic effects of the treatment, helping to manage the symptoms and progression of the disease.

Check Digit Verification of cas no

The CAS Registry Mumber 347841-46-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,4,7,8,4 and 1 respectively; the second part has 2 digits, 4 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 347841-46:
(8*3)+(7*4)+(6*7)+(5*8)+(4*4)+(3*1)+(2*4)+(1*6)=167
167 % 10 = 7
So 347841-46-7 is a valid CAS Registry Number.

347841-46-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name (4R)-4-[(3R,5R,7S,8R,9S,10S,13R,17R)-2,2,4,4-tetradeuterio-3,7-dihydroxy-10,13-dimethyl-3,5,6,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:347841-46-7 SDS

347841-46-7Upstream product

347841-46-7Downstream Products

347841-46-7Relevant academic research and scientific papers

Syntheses with stable isotopes: synthesis of deuterium and 13C labeled bile acids

Hachey,Szczepanik,Berngruber,Klein

, p. 703 - 719 (2007/10/16)

A series of 5β cholanic acids labeled with deuterium in the A ring were prepared by exchange labeling of the corresponding ketone by column chromatography on deuterated alumina. Factors affecting yield and labeling efficiency are discussed. 5β Cholanic acids labeled with 13C in the carboxyl position were prepared by treatment of the corresponding 23 chloro 24 norcholane with sodium cyanide 13C followed by alkaline hydrolysis of the nitrile. The intermediates in the synthesis were characterized by high resolution NMR spectroscopy. Mass spectra are also reported for the 13C labeled products.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 347841-46-7